Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-10

FDA Approved: TOBRAMYCIN INHALATION — Supplemental Application (Prasco, LLC)

View source ↗

Summary

The FDA approved a supplemental application from Prasco, LLC for Tobramycin Inhalation, authorizing a supplemental approval of a generic inhaled tobramycin prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TOBRAMYCIN INHALATION (TOBRAMYCIN)

Snippet

SUPPL AP for TOBRAMYCIN INHALATION (TOBRAMYCIN INHALATION)